FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yet

Overview of attention for news story in Nature Reviews Drug Discovery

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 105 X posts from 100 X users, with an upper bound of 345,020 followers.

RT @NatRevDrugDisc: FDA approves gene therapy for metachromatic leukodystrophy https://t.co/E0p5OSrd1W Atidarsagene autotemcel (Lenmeldy)…

Gene Therapy coming in action!!!

RT @NatRevDrugDisc: FDA approves gene therapy for metachromatic leukodystrophy https://t.co/E0p5OSrd1W Atidarsagene autotemcel (Lenmeldy)…

RT @salonium: Fascinating read about the world's newest most expensive drug ($4M) A one-off treatment for metachromatic leukodystrophy, a…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 101 additional X posts.